Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Pharmacological Penile Rehabilitation in the Preservation of Erectile Function Following Bilateral Nerve-Sparing Radical Prostatectomy

Not Applicable

Terminated

Conditions: Penile Cancer
Radical Prostatectomy
Erectile Dysfunction

Interventions: Drug: Sildenafil and questionnaire
Drug: Placebo QHS and sildenafil and questionnaires
Drug: Trimix combination (Papavarine 30mg/mL Phentholamine 1mg/mL Prostaglandin E1 10 mcg/mmL) and questionnaires

First Posted Date: 2009-08-10

Last Posted Date: 2021-11-10

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 76

Registration Number: NCT00955929

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Motion Correction in Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) in Ovarian Cancer: A Pilot Study

Completed

Conditions: Ovarian Cancer

Interventions: Procedure: DCE-MRI scans

First Posted Date: 2009-07-24

Last Posted Date: 2013-10-24

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 2

Registration Number: NCT00946140

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Application of Magnetic Resonance Fat-Free Imaging

Terminated

Conditions: Sarcoma

Interventions: Procedure: Fat-free MRI images utilizing standard magnetization, Questionnaire before the MRI exam

First Posted Date: 2009-07-23

Last Posted Date: 2014-05-15

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 2

Registration Number: NCT00944476

Locations: 🇺🇸
Memorial Sloan-Kettering CancerCenter, New York, New York, United States

Gynecologic Cancer Lymphedema Questionnaire as a Clinical Care Tool to Identify Lower Extremity Lymphedema

Completed

Conditions: Ovarian Cancer
Uterine Cancer
Vaginal Cancer
Lymphedema

Interventions: Behavioral: GCLQ lymphedema symptom assessment questionnaire
Behavioral: limb volume measurements and GCLQ lymphedema symptom assessment questionnaire

First Posted Date: 2009-07-23

Last Posted Date: 2010-02-01

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 58

Registration Number: NCT00944944

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Assessment of Comskil Training Through Videorecording and Patient Surveys

Completed

Conditions: Comskil Training

Interventions: Behavioral: video-recording and completing a survey

First Posted Date: 2009-07-22

Last Posted Date: 2016-08-16

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 55

Registration Number: NCT00943813

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Analysis of Surgery in Patients Presenting With Stage IV Breast Cancer

Active, not recruiting

Conditions: Breast Cancer

First Posted Date: 2009-07-20

Last Posted Date: 2024-07-15

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 100

Registration Number: NCT00941759

Locations: 🇺🇸
The Indiana University Simon Cancer Center, Indianapolis, Indiana, United States
🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Md Anderson Cancer Center, Houston, Texas, United States

and more 16 locations

Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia

Phase 1

Completed

Conditions: Leukemia
Acute Lymphoblastic Leukemia

Interventions: Drug: Dasatinib, Mitoxantrone, Cytarabine

First Posted Date: 2009-07-16

Last Posted Date: 2014-04-10

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 7

Registration Number: NCT00940524

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck Cancer

Phase 1

Completed

Conditions: HEAD & NECK Cancer

Interventions: Drug: RAD001 + docetaxel + cisplatin

First Posted Date: 2009-07-09

Last Posted Date: 2013-08-09

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 18

Registration Number: NCT00935961

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center, Sleepy Hollow, New York, United States
🇺🇸
Memorial Sloan-Kettering Cancer Center at Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan-Kettering Cancer Center at Commack, Commack, New York, United States

and more 2 locations

Patient Communication Training Intervention

Completed

Conditions: Cancer

Interventions: Behavioral: Questionnaires and training workshop

First Posted Date: 2009-07-07

Last Posted Date: 2011-11-23

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 32

Registration Number: NCT00933855

Locations: 🇺🇸
Queens Hospital Center, Jamaica, New York, United States

Modifications to Radical Prostatectomy: Feasibility Study

Not Applicable

Completed

Conditions: Prostate Cancer

Interventions: Procedure: radical prostatectomy with urethral irrigation but no fascial suturing, QOL forms
Procedure: radical prostatectomy with both urethral irrigation and fascial suturing, QOL forms
Procedure: radical prostatectomy with neither urethral irrigation nor fascial suturing, QOL forms
Procedure: radical prostatectomy with fascial suturing but no urethral irrigation, QOL forms

First Posted Date: 2009-06-26

Last Posted Date: 2019-11-21

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 154

Registration Number: NCT00928850

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy